THRD - Total Utang marang Modal Third Harmonic Bio Inc
The price trend visualization for the total debt-to-equity ratio of Third Harmonic Bio (THRD) is 0.01. Business protection relies on exclusive rights to dermatological formulas, although the cost of FDA certification renders this barrier volatile. Drug development is complicated by international conflicts and sanction risks regarding reagents. Operational stability is guaranteed by a strictly calibrated system for transporting fragile compounds between laboratories and medical centers.
%20-%20Rasio%20Kabeh%20Utang%20marang%20Dana%20Pribadi&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_THRD_-_Third-Harmonic-Bio_-_All-Debt-to-Shareholders-Equity-Ratio "THRD (Third Harmonic Bio) riwayat Total Utang marang Modal saka 28.04.2023 nganti 16.08.2025 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan Third Harmonic Bio
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Third Harmonic Bio|THRD - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Third Harmonic Bio|THRD - Gunggung utang perusahaan|Utang marang nilai buku Third Harmonic Bio|THRD - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Third Harmonic Bio|Likuiditas cepet thirdharmonicbio.com
- informasi bathi lan kelipatan valuasi:
Analisis dhasar perusahaan:Third Harmonic Bio, Inc.
The fabless model of Third Harmonic Bio (THRD), which outsources molecule synthesis to CMO plants, minimizes capital expenditures and directly impacts the balance sheet structure. By analyzing the business's leverage ratio, an investor assesses the proportion of liabilities to equity, where rising indebtedness amid stagnating revenues signals a risk of losing financial stability and a potential cash flow gap.
Analisis pesaing Third Harmonic Bio
Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|PVLA: Rasio Total Utang marang Ekuitas|Savara Pharma - Utang Agregat marang Modal|RIGL: Total Utang marang Modal|anaptysbio.com - Rasio Kabeh Utang marang Dana Pribadi|ATXS (Astria Therapeutics, Inc.) - Total Utang marang Modal|enGene Holdings Inc (ENGN) - Koefisien Total Utang marang Modal|Utang marang Ekuitas RAPT Therapeutics, Inc. (RAPT)|JBIO (aerovatetx.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ACRS (Aclaris Therapeutics)|KYTX: Rasio Utang marang Ekuitas|TLSA: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi CABA (Cabaletta Bio Inc.)|VTYX: Total Utang marang Modal|Theratechnologies, Inc - Rasio Kabeh Utang marang Dana Pribadi|AVTX (Avalo Therapeutics, Inc) - Total Utang marang Modal|Total Utang marang Modal eledon.com|Utang marang Ekuitas Agenus Inc. (AGEN)|CLYM (Climb Bio Inc.) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Zura Bio Limited ZURA|ATYR - Rasio Total Utang marang Ekuitas|ADAG - Utang marang Ekuitas|Utang marang Modal ImageneBio Inc|shattucklabs.com (STTK) - Utang marang Ekuitas|Rasio Utang marang Ekuitas EQ|CNTB (Connect Biopharma Holdings) - Total Utang marang Modal|Immunic Inc (IMUX) - Koefisien Total Utang marang Modal|Total Utang marang Modal ATRA|Rasio Total Utang marang Ekuitas inflarx.de IFRX|X4 Pharmaceuticals, Inc. - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ACET|Celularity Corp - Total Utang marang Modal|INMB: Utang marang Ekuitas|BRNS: Total Utang marang Modal|KZR - Koefisien Total Utang marang Modal|Utang marang Ekuitas SAB Biotherapeutics, Inc.|Utang marang Modal Akari Therapeutics PLC AKTX|Rasio Total Utang marang Ekuitas ENLV (Enlivex Therapeutics)|Utang Agregat marang Modal QTTB|Total Utang marang Modal GOVX (GeoVax Labs, Inc.)|Rasio Kabeh Utang marang Dana Pribadi EDSA|IBIO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi CARM (Carisma Therapeutics)|XTLB: Total Utang marang Modal|Rasio Utang marang Ekuitas BOLT|Utang marang Ekuitas HCW Biologics, Inc.|Aptevo - Utang Agregat marang Ekuitas|Total Utang marang Modal AIM|ADTX (aditxt.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal GRI (GRI Bio Corp)|Total Utang marang Modal XORTX Corp XRTX|HIND - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi REVB (revbiosciences.com)|Indaptus Therapeutics, Inc. (INDP) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Scinai Immunotherapeutics Ltd|CALI (CalciMedica Inc) - Total Utang marang Modal|Total Utang marang Modal Affimed Therapeutics|Rasio Total Utang marang Ekuitas ALLK (Allakos Inc.)|HOOK (hookipapharma.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal IGMS (IGM Biosciences)|Koefisien Total Utang marang Modal iTeos Therapeutics Inc (ITOS)|OCEA - Utang marang Ekuitas|TC BioPharm Ltd (TCBP) - Rasio Total Utang marang Ekuitas